Literature DB >> 26743641

Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada.

José L Pereira1, Martin R Chasen2, Sean Molloy3, Heidi Amernic4, Michael D Brundage5, Esther Green6, Serena Kurkjian7, Monika K Krzyzanowska8, Wenonah Mahase4, Omid Shabestari9, Reena Tabing4, Christopher A Klinger10.   

Abstract

CONTEXT: Cancer patients experience a high symptom burden throughout their illness. Despite this, patients' symptoms and needs are often not adequately screened for, assessed, and managed.
OBJECTIVES: This study investigated the attitudes of cancer care professionals toward standardized systematic symptom assessment and the Edmonton Symptom Assessment System (ESAS) and their self-reported use of the instrument in daily practice in a large healthcare jurisdiction where this is routine.
METHODS: A 21-item electronic survey, eliciting both closed and open-ended anonymous responses, was distributed to all 2806 cancer care professionals from four major provider groups: physicians, nurses, radiotherapists, and psychosocial oncology (PSO) staff at the 14 Regional Cancer Centres across Ontario, Canada.
RESULTS: A total of 1065 questionnaires were returned (response rate: 38%); 960 were eligible for analysis. Most respondents (88%) considered symptom management to be within their scope of practice. Sixty-six percent of physicians considered the use of standardized tools to screen for symptoms as "best practice," compared to 81% and 93% of nurses and PSO staff, respectively. Sixty-seven percent of physicians and 85% of nurses found the ESAS to be a useful starting point to assess patients' symptoms. Seventy-nine percent of physicians looked at their patient's ESAS scores at visits either "always" or "often," compared to 29%, 66%, and 89% of radiotherapists, PSO staff, and nurses, respectively. Several areas for improvement of ESAS use and symptom screening were identified.
CONCLUSION: Findings show significant albeit variable uptake across disciplines in the use of the ESAS since program initiation. Several barriers to using the ESAS in daily practice were identified. These need to be addressed.
Copyright © 2016 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer professionals; ESAS; Edmonton Symptom Assessment System; PROM; PROs; patient-reported outcome measurement; patient-reported outcomes; systematic symptom assessment

Mesh:

Year:  2015        PMID: 26743641     DOI: 10.1016/j.jpainsymman.2015.11.023

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  21 in total

Review 1.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

2.  Factors influencing the use by radiation therapists of cancer symptom guides: a mixed-methods study.

Authors:  C Ludwig; J Renaud; L Barbera; M Carley; C Henry; L Jolicoeur; C Kuziemsky; A Patry; D Stacey
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

3.  Early palliative care: taking ownership and creating the conditions.

Authors:  J Pereira; M R Chasen
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

4.  Comprehensive metastatic lung cancer care must include palliative care.

Authors:  A M Rosenblum; M Chasen
Journal:  Curr Oncol       Date:  2018-06-28       Impact factor: 3.677

5.  Gaps in the Management of Depression Symptoms Following Cancer Diagnosis: A Population-Based Analysis of Prospective Patient-Reported Outcomes.

Authors:  Julie Hallet; Laura E Davis; Elie Isenberg-Grzeda; Alyson L Mahar; Haoyu Zhao; Victoria Zuk; Lesley Moody; Natalie G Coburn
Journal:  Oncologist       Date:  2020-02-26

6.  Factors associated with receipt of symptom screening in the year after cancer diagnosis in a universal health care system: a retrospective cohort study.

Authors:  A L Mahar; L E Davis; L D Bubis; Q Li; R Sutradhar; N G Coburn; L Barbera
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

7.  Population-based study of the prevalence and management of self-reported high pain scores in patients with non-resected pancreatic adenocarcinoma.

Authors:  S Tung; N G Coburn; L E Davis; A L Mahar; S Myrehaug; H Zhao; C C Earle; A Nathens; J Hallet
Journal:  Br J Surg       Date:  2019-11       Impact factor: 6.939

8.  An explorative study on systematic assessment of QOL and care needs with the CARES-SF in the early follow-up of patients with digestive cancer.

Authors:  Bojoura Schouten; Dominiek De Jonckheere; Marc Aerts; Jochen Decaestecker; Daan Walgraeve; Patrick Vankrunkelsven; Johan Hellings
Journal:  Support Care Cancer       Date:  2018-11-29       Impact factor: 3.603

Review 9.  Patient-reported outcomes in cancer care - hearing the patient voice at greater volume.

Authors:  Thomas W LeBlanc; Amy P Abernethy
Journal:  Nat Rev Clin Oncol       Date:  2017-10-04       Impact factor: 66.675

10.  Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.

Authors:  M Moskovitz; K Jao; J Su; M C Brown; H Naik; L Eng; T Wang; J Kuo; Y Leung; W Xu; N Mittmann; L Moody; L Barbera; G Devins; M Li; D Howell; G Liu
Journal:  Curr Oncol       Date:  2019-12-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.